Posted by SLS on May 23, 2012, at 17:35:37
In reply to is anyone actually impressed with drug companies?, posted by poser938 on May 23, 2012, at 16:52:40
> from the days of MAOI's and tricyclics, the main advantage they have with newer meds is it is much more difficult to overdose and have a fatal reaction. besides that, the older meds could work as well if not better than the newer medications they have out. and now they're saying that the future is in Triple Reuptake Inhibitors. i just think it's a joke. it is nothing more than combining the actions of medications we already have out today.
I really don't think that it is a joke.
I don't think we can consider Wellbutrin to be a DA reuptake inhibitor to the same degree as are amineptine and nomifensine, two drugs that were discontinued.
Which other drugs do you consider to be DA reuptake inhibitors that we could use in combination treatments?
> article on triple reuptake inhibitors being the future.
> http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701280/I am impressed by the personages and technology employed in the research and development areas of pharmaceutical companies. I am less impressed with their business decisions and marketing campaigns. If it makes you feel any better, the few triple reuptake inhibitor projects that were listed on the http://www.neurotransmitter.net/newdrugs.html site have disappeared. Perhaps they were abandoned. Do you know of any that are still in the pipeline?
- Scott
Some see things as they are and ask why.
I dream of things that never were and ask why not.- George Bernard Shaw
poster:SLS
thread:1018564
URL: http://www.dr-bob.org/babble/20120522/msgs/1018567.html